Incidence of Invasive Pneumococcal Disease among Individuals with Sickle Cell Disease before and after the Introduction of the Pneumococcal Conjugate Vaccine | Zendy

Natasha Halasa | Zendy; S. M. Shankar | Zendy; Thomas R. Talbot | Zendy; Patrick G. Arbogast | Zendy; Edward F. Mitchel | Zendy; W. C. Wang | Zendy; W. Schaffner | Zendy; Allen S. Craig | Zendy; Marie R. Griffin | Zendy

Open Access

Incidence of Invasive Pneumococcal Disease among Individuals with Sickle Cell Disease before and after the Introduction of the Pneumococcal Conjugate Vaccine

Author(s) -

Natasha Halasa,

S. M. Shankar,

Thomas R. Talbot,

Patrick G. Arbogast,

Edward F. Mitchel,

W. C. Wang,

W. Schaffner,

Allen S. Craig,

Marie R. Griffin

Publication year - 2007

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/516781

Subject(s) - medicine , pneumococcal disease , incidence (geometry) , pneumococcal conjugate vaccine , disease , pneumococcal infections , immunology , streptococcus pneumoniae , conjugate vaccine , pediatrics , immunization , immune system , antibiotics , microbiology and biotechnology , biology , physics , optics

We sought to determine the incidence of invasive pneumococcal disease (IPD) among individuals with sickle cell disease (SCD) before and after the introduction of the pneumococcal conjugate vaccine (PCV).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research